(Legend Biotech), a global leader in cell therapy, will host a live webcast event for investors on Sunday, December 8, 2024, at 8:00 p.m. PT (11:00 p.m. ET) during the 66th American Society of ...

(Legend Biotech), a global leader in cell therapy, will host a live webcast event for investors on Sunday, December 8, 2024, at 8:00 p.m. PT (11:00 p.m. ET) during the 66th American Society of ...

Cell therapy biotech Tolerance Bio has unveiled with $17.2 million and a mission of targeting immune diseases by stretching and saving the function of a key organ. The Philadelphia biotech’s ...

Allison DeAngelis, who covers biotech startups and venture capital, is also the author of STAT’s annual report “Ranking Biotech’s Top Venture Capital Firms.” Biotech investors have been ...

Commissions do not affect our editors' opinions or evaluations. Biotech stocks are not for the faint of heart. These highly volatile equities can see stomach-churning price swings, driven by how ...

PharmAla Biotech Holdings Inc. MDXXF has announced that it will supply its Good Manufacturing Practice LaNeo MDMA for a clinical trial at Mt. Sinai Health System. The biotechnology company ...

The United States's dominance in biotech innovation is crucial to our ... All players in the drug development and supply chain are driven by financial incentives. Without regulatory distortions ...

Even during this tense election year, bipartisan coalitions are taking steps to enhance national security, protect American ... the domestic supply chain that renders robust biotech innovation ...

Syngene (CMP: Rs 875; Market cap: Rs 35,216 crore; Rating: Overweight), the leading CRAMS (contract research and manufacturing services) player, posted a sequential growth in its Q2FY25 results.

Chiesi Group is making a strategic investment of €400 million to establish its new Biotech Center of Excellence in Parma The Center is designed to integrate the entire supply chain, enhancing ...